ProCE Banner Activity

Conducting Research in a Pandemic: How We Are Getting Breast Cancer Trials Back up and Running

Clinical Thought

COVID-19 has presented many barriers to conducting clinical trials, but I am optimistic that the end results will improve our long-term efficiency in opening and operating trials and offering new treatment options.

Released: September 28, 2020

Expiration: September 30, 2024

Share

Faculty

Hope S. Rugo

Hope S. Rugo, MD

Clinical Professor of Medicine
UCSF Comprehensive Cancer Center
University of California, San Francisco
San Francisco, California

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

Daiichi Sankyo, Inc.

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Hope S. Rugo, MD

Clinical Professor of Medicine
UCSF Comprehensive Cancer Center
University of California, San Francisco
San Francisco, California

Hope S. Rugo, MD, has disclosed that she has received funds for research support from Amgen, Daiichi, Eisai, Genentech, Immunomedics, Lilly, MacroGenics, Merck, Novartis, OBI, Odonate, Pfizer, and Seattle Genetics and support for travel from Amgen, AstraZeneca, Daiichi, MacroGenics, Merck, Mylan, Pfizer, and Puma.